|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,149.40 INR | +0.33% |
|
-7.66% | -14.58% |
| 13/02 | Jefferies Adjusts Concord Biotech's Price Target to INR1,170 From INR1,290, Keeps at Hold | MT |
| 12/02 | Concord Biotech Limited, Q3 2026 Earnings Call, Feb 12, 2026 |
EPS & Dividend: Concord Biotech Limited
| Fiscal Period: March | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Dividend per Share 2 | 8.75 | 10.7 | 11.42 | 12.88 | 14.92 |
| Rate of return | 0.58% | 0.64% | 1% | 1.12% | 1.3% |
| EPS 2 | 29.45 | 35.52 | 30.14 | 38.96 | 48.88 |
| Distribution rate | 29.7% | 30.1% | 37.9% | 33% | 30.5% |
| Reference price 2 | 1,520.80 | 1,680.60 | 1,145.60 | 1,145.60 | 1,145.60 |
| Nbr of stocks (in thousands) | 1,04,616 | 1,04,616 | 1,04,616 | - | - |
| Announcement Date | 24/05/24 | 29/05/25 | - | - | - |
1INR in Million2INR
Estimates
Past dividends: Concord Biotech Limited
| 03/09/2025 | Annual 10.7 INR |
| 21/06/2024 | Annual 8.75 INR |
Upcoming events: Concord Biotech Limited
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1% | 1.12% | 38x | 5.9x | 9.65x | |
| 0.49% | 0.57% | 20.1x | 2.38x | 4.65x | |
| 0.5% | 0.51% | 45.43x | 5.01x | 7.13x | |
| -.--% | -.--% | 51.52x | 6.93x | 13.6x | |
| 2.73% | 2.98% | 37.36x | 2.66x | 3.83x | |
| -.--% | -.--% | 16.48x | 1.41x | 3.04x | |
| -.--% | -.--% | 15.9x | 2.74x | 2.61x | |
| -.--% | 0.22% | 80.68x | 7.88x | 9.49x | |
| -.--% | -.--% | -5.57x | 2x | 6.56x | |
| -.--% | -.--% | 691.31x | 3.57x | 5.37x | |
| Average | 0.47% | 0.54% | 99.12x | 4.05x | 6.59x | |
| Weighted average by Cap. | 0.6% | 0.67% | 63.56x | 3.89x | 6.53x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition